VALN - FDA approves Valneva's world-first chikungunya vaccine
2023-11-10 04:26:41 ET
More on Valneva
- Valneva SE (VALN) Q3 2023 Earnings Call Transcript
- Valneva's Vaccination Valor: A Buy Rating Justified
- Valneva SE (VALN) Q2 2023 Earnings Call Transcript
- Valneva reports 9M results
- FDA finds no issues in Pfizer/ Valneva Lyme disease vaccine trial
For further details see:
FDA approves Valneva's world-first chikungunya vaccine